Please login to the form below
15
Revenue 2017Neulasta
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Neulasta was produced by Amgen.
Sandoz finally wins FDA approval for Neulasta biosimilar
Amgen had a lucky break when the FDA initially rejected Sandoz’ Neulasta biosimilar back in 2016, as the US market accounts for the bulk of its sales for this medicine. ... Neulasta had been one of Amgen’s biggest commercial products, but has been
Amgen exits neuroscience R&D to focus on growth areas
Away from its neuroscience news, Amgen reported a 3% decline in revenues to $5.74bn on its third-quarter update, with red blood cell stimulators Neupogen and Neulasta both plummeting around
Amgen buys Danish partner Nuevolution for $167m
The company is starting to face biosimilar competition for white blood cell stimulator Neulasta (pegfilgrastim) as well as generic encroachment on Sensipar (cinacalcet) for secondary hyperparathyroidism, which together accounted for around
Amgen CEO says Aimovig is “one of most successful launches”
Overall, Amgen posted a 2% rise in revenues to $5.78bn in the quarter, despite pressure on older drugs like while blood cell booster Neulasta (pegfilgrastim) which showed the first signs
Alnylam’s amyloidosis drug heads latest crop of CHMP approvals
and ERA Consulting’s Udenyca (pegfilgrastim), both alternatives to Amgen’s Neulasta brand for neutropenia and febrile neutropenia due to chemotherapy.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
